Document:

Exhibit 10.1

 

SUBSCRIPTION
AGREEMENT

 

SUBSCRIPTION
AGREEMENT (this “Subscription Agreement”) made as of the last date set forth on the signature page hereof between
Avant Diagnostics, Inc., a Nevada corporation (the “Company”), and the undersigned (the “Subscriber”).

 

W
I T N E S S E T H:

 

WHEREAS,
the Company is conducting a private offering (the “Offering”) consisting of up to 1,500,000 shares of the Company’s
series A convertible preferred stock, par value $0.001 per share (the “Preferred Stock”), each share of Preferred
Stock having a stated value of $1.00 per share (the “Stated Value”) and convertible into shares of the Company’s
common stock, par value $0.00001 per share (the “Common Stock”) at a conversion price of $0.015 per share, subject
to adjustment, with each share to be sold at a negotiated price of $1.00 per share (the “Offering Price”);

 

WHEREAS,
the Offering is on a “reasonable efforts” basis as to the shares of Preferred Stock to be sold up to the maximum offering
amount of $1,500,000 (the “Maximum Offering”), provided however that the Placement Agent and the Company may agree
to increase the Maximum Offering amount up to $2,000,000 without prior notice to the Subscribers, to a limited number of “accredited
investors” (as that term is defined by Rule 501(a) of Regulation D (“Regulation D”) promulgated under the Securities
Act of 1933, as amended (the “Securities Act”);

  

WHEREAS,
the Company and each Subscriber is executing and delivering this agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D as promulgated by the SEC under the Securities
Act; and

 

WHEREAS
the subscription for the Securities will be made in accordance with and subject to the terms and conditions of this Subscription
Agreement and the Company’s Confidential Private Placement Memorandum dated February 16, 2018, together with all amendments
thereof and supplements and exhibits thereto and as such may be amended from time to time (the “Memorandum”); and

 

WHEREAS,
the Subscriber desires to purchase such number of shares of Preferred Stock as set forth on the signature page hereof on the terms
and conditions hereinafter set forth.

 

    1

     

    

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

I.
SUBSCRIPTION FOR SHARES AND REPRESENTATIONS BY SUBSCRIBER

 

1.1
Subject to the terms and conditions hereinafter set forth (including Section 1.19 hereof) and as set forth in the Memorandum,
the Subscriber hereby subscribes for and agrees to purchase from the Company, and the Company agrees to sell to the Subscriber,
such number of shares of Preferred Stock as is set forth on the signature page hereof. The purchase price is payable by wire transfer,
to be held in escrow until a closing occurs, to the Company as follows:

 

Bank:

Address:

Tel:

ABA

Account
#:

FBO:

 

1.2
The Subscriber understands acknowledges and agrees that, except as otherwise set forth in Section 3.2 herein or otherwise required
by law, that once irrevocable, the Subscriber is not entitled to cancel, terminate or revoke this Subscription Agreement or any
agreements of the Subscriber hereunder and that this Subscription Agreement and such other agreements shall survive the death
or disability of the Subscriber and shall be binding upon and inure to the benefit of the parties and their heirs, executors,
administrators, successors, legal representatives and permitted assigns. If the Subscriber is more than one person, the obligations
of the Subscriber hereunder shall be joint and several and the agreements, representations, warranties and acknowledgments herein
contained shall be deemed to be made by and be binding upon each such person and his/her heirs, executors, administrators, successors,
legal representatives and permitted assigns

 

1.3
The Subscriber recognizes that the purchase of the Securities involves a high degree of risk including, but not limited to, the
following: (a) the Company requires substantial funds in addition to the proceeds of the Offering; (b) an investment in the Company
is highly speculative, and only investors who can afford the loss of their entire investment should consider investing in the
Company and the Securities; (c) the Subscriber may not be able to liquidate his, her or its investment; (d) transferability of
the Securities (including any securities issuable upon conversion and/or exercise of the Securities) is extremely limited; (e)
in the event of a disposition, the Subscriber could sustain the loss of its entire investment; and (f) the Company has not paid
any dividends since its inception and does not anticipate paying any dividends.

 

1.4
At the time such Subscriber was offered the Securities, it was, and as of the date hereof it is, and on each date on which it
converts the Preferred Stock, it will be an “accredited investor” as defined in Rule 501(a) under the Securities Act,
as indicated by the Subscriber’s responses to the investor questionnaire attached as Exhibit A to this Subscription Agreement,
and that the Subscriber is able to bear the economic risk of an investment in the Securities.

 

    2

     

    

 

1.5
The Subscriber hereby acknowledges and represents that (a) the Subscriber has adequate means of providing for the Subscriber’s
current financial needs and contingencies, (b) the Subscriber has knowledge and experience in business and financial matters,
prior investment experience, including investment in securities that are non-listed, unregistered and/or not traded on a national
securities exchange or the Subscriber has employed the services of a “purchaser representative” (as defined in Rule
501 of Regulation D), attorney and/or accountant to read all of the documents furnished or made available by the Company both
to the Subscriber and to all other prospective investors in the Securities to evaluate the merits and risks of such an investment
on the Subscriber’s behalf; (c) the Subscriber recognizes the highly speculative nature of this investment; (d) the Subscriber
is able to bear the economic risk that the Subscriber hereby assumes, (e) the Subscriber could afford a complete loss of such
investment in the Securities.

 

1.6
The Subscriber hereby acknowledges receipt and careful review of this Subscription Agreement, the Memorandum, the certificate
of designation to be filed with the Secretary of State of the State of Nevada for the Preferred Stock (the “Certificate
of Designations”) and all other exhibits, annexes and appendices thereto (collectively referred to as the “Offering
Materials”), and has had access to the Company’s periodic and current reports filed with the United States Securities
and Exchange Commission (the “SEC”) as publicly filed with and available at the website of the SEC which can be accessed
at www.sec.gov, and hereby represents that the Subscriber has been furnished by the Company during the course of the Offering
with all information regarding the Company, the terms and conditions of the Offering and any additional information that the Subscriber
has requested or desired to know, and has been afforded the opportunity to ask questions of and receive answers from duly authorized
officers or other representatives of the Company concerning the Company and the terms and conditions of the Offering; provided,
however that no investigation performed by or on behalf of the Subscriber shall limit or otherwise affect its right to rely on
the representations and warranties of the Company contained herein. By the date of signature to this Subscription Agreement, the
Subscriber (along with its advisors) acknowledges its ability to conduct its own due diligence, research and evaluation of the
financial condition and integrity of the parties involved and the particular transaction, and affirms it has made its own appraisal
of, and investigation into, the Company’s business, property, financial and other condition and creditworthiness which has
been completed to the Subscriber’s total satisfaction.

 

1.7
(a) In making the decision to invest in the Securities, the Subscriber has relied solely upon the information provided by
the Company in the Offering Materials. To the extent necessary, the Subscriber has retained, at its own expense, and relied
upon appropriate professional advice regarding the investment, tax and legal merits and consequences of this Subscription
Agreement and the purchase of the Securities hereunder. The Subscriber disclaims reliance on any statements made or
information provided by any person or entity in the course of Subscriber’s consideration of an investment in the
Securities other than the Offering Materials and the results of Subscriber’s own independent investigation.

 

    3

     

    

 

(b) The
Subscriber represents that (i) the Subscriber was contacted regarding the sale of the Securities by the Company or the Placement
Agent (or another person whom the Subscriber believed to be an authorized agent or representative thereof) with whom the Subscriber
had a prior substantial pre-existing relationship and (ii) it did not learn of the offering of the Securities by means of any
form of general solicitation or general advertising, and in connection therewith, the Subscriber did not (A) receive or review
any advertisement, article, notice or other communication published in a newspaper or magazine or similar media or broadcast over
television or radio, whether closed circuit, or generally available; or (B) attend any seminar meeting or industry investor conference
whose attendees were invited by any general solicitation or general advertising.

 

1.8
The Subscriber hereby acknowledges that the Offering has not been reviewed by the SEC nor any state regulatory authority since
the Offering is intended to be exempt from the registration requirements of Section 5 of the Securities Act, pursuant to Section
4(a)(2) of the Securities Act and Rule 506 of Regulation D. The Subscriber understands that the Securities have not been registered
under the Securities Act or under any state securities or “blue sky” laws and agrees not to sell, pledge, assign or
otherwise transfer or dispose of the Securities unless they are registered under the Securities Act and under any applicable state
securities or “blue sky” laws or unless an exemption from such registration is available.

 

1.9
The Subscriber understands that the Securities (have not been registered under the Securities Act by reason of a claimed exemption
under the provisions of the Securities Act that depends, in part, upon the Subscriber’s investment intention. In this connection,
the Subscriber hereby represents that the Subscriber is purchasing the Securities for the Subscriber’s own account for investment
and not with a view toward the resale or distribution to others; provided, however, that nothing contained herein shall constitute
an agreement by the Subscriber to hold the Securities for any particular length of time and the Company acknowledges that the
Subscriber shall at all times retain the right to dispose of its property as it may determine in its sole discretion, subject
to any restrictions imposed by applicable law. The Subscriber, if an entity, further represents that it was not formed for the
purpose of purchasing the Securities.

 

1.10 
The Subscriber consents to the placement of a legend on any certificate or other document evidencing the Securities and, that
such securities have not been registered under the Securities Act or any state securities or “blue sky” laws and setting
forth or referring to the restrictions on transferability and sale thereof contained in this Subscription Agreement. The Subscriber
is aware that the Company will make a notation in its appropriate records with respect to the restrictions on the transferability
of such Securities. The legend to be placed on each certificate shall be in form substantially similar to the following:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”)
OR ANY STATE SECURITIES OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED
ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE
COMPANY HAS RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS
NOT REQUIRED.”

 

    4

     

    

 

1.11
The Subscriber hereby represents that the address of the Subscriber furnished by Subscriber on the signature page hereof is the
Subscriber’s principal residence if Subscriber is an individual or its principal business address if it is a corporation
or other entity.

 

1.12
The Subscriber represents that the Subscriber has full power and authority (corporate, statutory and otherwise) to execute
and deliver this Subscription Agreement and to purchase the Securities. This Subscription Agreement constitutes the legal,
valid and binding obligation of the Subscriber, enforceable against the Subscriber in accordance with its terms.

 

1.13
If the Subscriber is a corporation, partnership, limited liability company, trust, employee benefit plan, individual
retirement account, Keogh Plan, or other tax-exempt entity, it is authorized and qualified to invest in the Company and the
person signing this Subscription Agreement on behalf of such entity has been duly authorized by such entity to do
so.

 

1.14
The Subscriber acknowledges that if he or she is a Registered Representative of a Financial Industry Regulatory Authority (“FINRA”)
member firm, he or she must give such firm the notice required by the FINRA’s Rules of Fair Practice, receipt of which must
be acknowledged by such firm.

 

1.15
To effectuate the terms and provisions hereof, until the consummation of the Reverse Split (as defined herein), the Subscriber
hereby appoint ADVX Investor Group LLC (the “Investor Representative”) as its attorney-in-fact (and the Investor Representative
hereby accepts such appointment) for the purpose of carrying out the Shareholder Approval (as defined herein) including, without
limitation, taking any action on behalf of, or at the instruction of, the Subscriber and executing any documentation required
and taking any action and executing any instrument that the Investor Representative may deem necessary or advisable (and lawful)
to accomplish the purposes hereof. All acts done under the foregoing authorization are hereby ratified and approved and neither
the Investor Representative nor any designee nor agent thereof shall be liable for any acts of commission or omission, for any
error of judgment, for any mistake of fact or law except for acts of gross negligence or willful misconduct. This power of attorney,
being coupled with an interest, is irrevocable while the until the Reverse Split is consummated.

 

1.16
The Subscriber agrees not to issue any public statement with respect to the Offering, Subscriber’s
investment or proposed investment in the Company or the terms of any agreement or covenant between them and the Company
without the Company’s prior written consent, except such disclosures as may be required under applicable
law.

 

1.17
The Subscriber understands, acknowledges and agrees with the Company that this subscription may be rejected, in whole or in part,
by the Company, in the sole and absolute discretion of the Company, at any time before any Closing notwithstanding prior receipt
by the Subscriber of notice of acceptance of the Subscriber’s subscription.

 

    5

     

    

 

1.18
The Subscriber acknowledges that the information contained in the Offering Materials or otherwise made available to the Subscriber
is confidential and non-public, has been delivered to it in reliance upon agreement to maintain the confidentiality of the information
and upon Regulation FD promulgated by the Commission, and agrees that all such information shall be kept in confidence by the
Subscriber and neither used by the Subscriber for the Subscriber’s personal benefit (other than in connection with this
subscription) nor disclosed to any third party for any reason, notwithstanding that a Subscriber’s subscription may not
be accepted by the Company; provided, however, that (a) the Subscriber may disclose such information to its affiliates and advisors
who may have a need for such information in connection with providing advice to the Subscriber with respect to its investment
in the Company so long as such affiliates and advisors have an obligation of confidentiality, and (b) this obligation shall not
apply to any such information that (i) is part of the public knowledge or literature and readily accessible at the date hereof,
(ii) becomes part of the public knowledge or literature and readily accessible by publication (except as a result of a breach
of this provision) or (iii) is received from third parties without an obligation of confidentiality (except third parties who
disclose such information in violation of any confidentiality agreements or obligations, including, without limitation, any subscription
or other similar agreement entered into with the Company).

 

1.19
The Subscriber understands that the Securities being offered and sold to it in reliance on specific exemptions from the
registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Subscriber’s compliance with, the representations, warranties, agreements,
acknowledgements and understandings of such Subscriber set forth herein in order to determine the availability of such
exemptions and the eligibility of such Subscriber to acquire the Securities. The Subscriber agrees to supply the Company,
within five (5) days after the Subscriber receives the request therefor from the Company, with such additional information
concerning the Subscriber as the Company deems necessary or advisable

 

1.20
The Subscriber understands that Rule 144 promulgated under the Act (“Rule 144”) requires, among other conditions,
a minimum holding period of six-months prior to the resale of securities acquired in a non-public offering without having to satisfy
the registration requirements under the Act. The Subscriber understands and hereby acknowledges that the Company is under no obligation
to register the Securities under the Act or any state securities or “blue sky” laws or to assist the Subscriber in
obtaining an exemption from various registration requirements, other than as set forth herein.

 

1.21
The Subscriber agrees to hold the Company and its directors, officers, employees, controlling persons and agents (including the
Placement Agent and its managers, members, officers, directors, employees, counsel, controlling persons and agents) and their
respective heirs, representatives, successors and assigns harmless from and to indemnify them against all liabilities, costs and
expenses incurred by them as a result of (i) any misrepresentation made by the Subscriber contained in this Subscription Agreement
(including Article VII hereunder) or breach of any warranty by the Subscriber in this Subscription Agreement or in any Exhibits
or Schedules attached hereto; (ii) any untrue statement of a material fact made by the Subscriber and contained herein; or (iii)
after any applicable notice and/or cure periods, any breach or default in performance by the Subscriber of any covenant or undertaking
to be performed by the Subscriber hereunder, or any other Offering Materials entered into by the Company and Subscriber relating
hereto. Notwithstanding the foregoing, in no event shall the liability of the Subscriber hereunder be greater than the aggregate
subscription amount paid for the Securities as set forth on the signature page hereto.

 

    6

     

    

 

1.22
If the Subscriber is purchasing the Securities in a fiduciary capacity for another person or entity, including without limitation
a corporation, partnership, trust or any other entity, the Subscriber has been duly authorized and empowered to execute this Subscription
Agreement and all other subscription documents, and such other person fulfills all the requirements for purchase of the Securities
as such requirements are set forth herein, concurs in the purchase of the Securities and agrees to be bound by the obligations,
representations, warranties and covenants contained herein. Upon request of the Company, the Subscriber will provide true, complete
and current copies of all relevant documents creating the Subscriber, authorizing its investment in the Company and/or evidencing
the satisfaction of the foregoing.

 

1.23
Neither the Subscriber nor, to the Subscriber’s knowledge, any of its directors, executive officers, other officers that
may serve as a director or officer of any company in which it invests, general partners or managing members is subject to any
Disqualification Events, except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) under the Securities
Act, and disclosed in writing in reasonable detail to the Company.

 

1.24
Each Subscriber understands that the Company is not current in its reporting obligations with the SEC and that the Company
was previously was a “shell company” as defined in Rule 12b-2 under the Exchange Act. Pursuant to Rule 144(i), securities
issued by a current or former shell company that otherwise meet the holding period and other requirements of Rule 144 nevertheless
cannot be sold in reliance on Rule 144 until one year after the Company (a) is no longer a shell company; and (b) has filed
current “Form 10 information“ (as defined in Rule 144(i)) with the SEC reflecting that it is no longer a shell company,
and provided that at the time of a proposed sale pursuant to Rule 144, the Company is subject to the reporting requirements of
Section 13 or 15(d) of the Exchange Act and has filed all reports and other materials required to be filed by Section 13 or 15(d)
of the Exchange Act, as applicable, during the preceding 12 months (or for such shorter period that the issuer was required to
file such reports and materials), other than Form 8-K reports. As a result, the restrictive legends on certificates for the
Preferred Stock and any Common Stock to be issued in exchange of such shares, cannot be removed except in connection with an actual
sale meeting the foregoing requirements or pursuant to an effective registration statement.

 

 

    7

     

    

 

II.
REPRESENTATIONS BY AND COVENANTS OF THE COMPANY

 

The
Company hereby represents and warrants to the Subscriber that:

 

2.1
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good
standing under the laws of the State of Colorado and has full corporate power and authority to own and use its properties and
its assets and conduct its business as currently conducted. Each of the Company’s subsidiaries (the “Subsidiaries”)
is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation with
the requisite corporate power and authority to own and use its properties and assets and to conduct its business as currently
conducted. Neither the Company, nor any of its Subsidiaries is in violation of any of the provisions of their respective articles
of incorporation, by-laws or other organizational or charter documents, including, but not limited to the Charter Documents (as
defined below). Each of the Company and its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, would not result in a direct and/or
indirect (i) material adverse effect on the legality, validity or enforceability of any of the Securities and/or this Subscription
Agreement, (ii) material adverse effect on the results of operations, assets, business, condition (financial and other) or
prospects of the Company and its Subsidiaries, taken as a whole, or (iii) material adverse effect on the Company’s ability
to perform in any material respect on a timely basis its obligations under the Offering Materials (as defined below) (any of (i),
(ii) or (iii), a “Material Adverse Effect”).

 

2.2
Authorization; Enforceability. The Company has all corporate right, power and authority to enter into, execute and deliver
this Subscription Agreement and each other agreement, document, instrument and certificate to be executed by the Company in connection
with the consummation of the transactions contemplated hereby, including, but not limited to the Offering Materials, and to perform
fully its obligations hereunder and thereunder. All corporate action on the part of the Company, its directors and stockholders
necessary for the (a) authorization execution, delivery and performance of this Subscription Agreement and the Offering Materials
by the Company; and (b) authorization, sale, issuance and delivery of the Securities contemplated hereby and the performance of
the Company’s obligations under this Subscription Agreement and the Offering Materials has been taken. This Subscription
Agreement and the Offering Materials have been duly executed and delivered by the Company and each constitutes a legal, valid
and binding obligation of the Company, enforceable against the Company in accordance with its respective terms, subject to laws
of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance,
injunctive relief or other equitable remedies, and to limitations of public policy. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Offering Materials, will be duly and validly issued, fully paid and nonassessable,
free and clear of all encumbrances other than restrictions on transfer provided for in the Offering Materials. Except as set forth
on Schedule 2.3 hereto, the issuance and sale of the Securities contemplated hereby will not give rise to any preemptive
rights or rights of first refusal on behalf of any person.

 

    8

     

    

 

2.3
No Conflict; Governmental Consents.

 

(a)
The execution and delivery by the Company of this Subscription Agreement and the Offering Materials, the issuance and sale
of the Securities and the consummation of the other transactions contemplated hereby or thereby do not and will not (i)
result in the violation of any law, statute, rule, regulation, order, writ, injunction, judgment or decree of any court or
governmental authority to or by which the Company is bound including without limitation all foreign, federal, state and local
laws applicable to its business and all such laws that affect the environment, except in each case as could not have or
reasonably be expected to result in a Material Adverse Effect, (ii) conflict with or violate any provision of the
Company’s Articles of Incorporation (the “Articles”), as amended or the Bylaws, (and collectively with the
Articles, the “Charter Documents”) of the Company, and (iii) conflict with, or result in a material breach or
violation of, any of the terms or provisions of, or constitute (with or without due notice or lapse of time or both) a
default or give to others any rights of termination, amendment, acceleration or cancellation (with or without due notice,
lapse of time or both) under any agreement, credit facility, lease, loan agreement, mortgage, security agreement, trust
indenture or other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them is bound
or to which any of their respective properties or assets is subject, nor result in the creation or imposition of any
Encumbrances upon any of the properties or assets of the Company or any Subsidiary.

 

(b)
Except for the Charter Amendment and the Reverse Stock Split as discussed in the Memorandum, no approval by the holders of
Common Stock, or other equity securities of the Company is required to be obtained by the Company in connection with the
authorization, execution, delivery and performance of this Subscription Agreement and the other Offering Materials or in
connection with the authorization, issue and sale of the Securities, except as has been previously obtained.

 

(c)
Except as set forth on Schedule 2.4 hereto, no consent, approval, authorization or other order of any governmental
authority or any other person is required to be obtained by the Company in connection with the authorization, execution,
delivery and performance of this Subscription Agreement and the other Offering Materials or in connection with the
authorization, issue and sale of the Securities and, upon issuance, the Underlying Shares, except such post-sale filings as
may be required to be made with the SEC, FINRA and with any state or foreign blue sky or securities regulatory authority, all
of which shall be made when required.

 

2.4
Consents of Third Parties. No vote, approval or consent of any holder of capital stock of the Company or any other third
parties is required or necessary to be obtained by the Company in connection with the authorization, execution, deliver and performance
of this Subscription Agreement and the other Offering Materials or in connection with the authorization, issue and sale of the
Securities and, upon issuance, the Warrant Shares, except as previously obtained, each of which is in full force and effect.

 

2.5
Brokers. Except for the Placement Agent as described in the Memorandum, neither the Company nor any of the Company's officers,
directors, employees or stockholders has employed or engaged any broker or finder in connection with the transactions contemplated
by this Subscription Agreement and no fee or other compensation is or will be due and owing to any broker, finder, underwriter,
placement agent or similar person in connection with the transactions contemplated by this Subscription Agreement. Except for
the Placement Agent, the Company is not party to any other agreement, arrangement or understanding whereby any person has an exclusive
right to raise funds and/or place or purchase any debt or equity securities for or on behalf of the Company.

 

    9

     

    

 

2.6
Bad Actor Disqualification

 

(a)
No Disqualification Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act ("Regulation D Securities"), none of the Company, any of its predecessors, any affiliated issuer, any
director, executive officer, other officer of the Company participating in the offering, any beneficial owner of 20% or more of
the Company's outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is
defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an "Issuer
Covered Person" and, together, "Issuer Covered Persons") is subject to any of the "Bad Actor" disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a "Disqualification Event"), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person
is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under
Rule 506(e), and has furnished to the Placement Agent and the Subscriber a copy of any disclosures provided thereunder.

 

(b)
Other Covered Persons. The Company is not aware of any person that (i) has been or will be paid (directly or indirectly)
remuneration for solicitation of purchasers in connection with the sale of the Securities and (ii) who is subject to a Disqualification
Event.  

 

(c)
Notice of Disqualification Events. The Company will notify the Placement Agent in writing of (i) any Disqualification Event
relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Issuer Covered Person, prior to any Closing of this Offering.

 

III.
TERMS OF SUBSCRIPTION

 

3.1
The Securities will be offered for sale until the earlier of (i) the date upon which subscriptions for the Maximum Offering offered
hereunder have been accepted, (ii) October 30, 2018 or (iii) the date upon which the Company and the Placement Agent elect to
terminate the Offering (the “Termination Date”). The Offering is being conducted on a “reasonable efforts”
basis for the Maximum Offering.

 

3.2
The Company may hold an initial closing (“Initial Closing”) at any time after the receipt of accepted subscriptions
by the Company. After the Initial Closing, subsequent closings with respect to additional Securities may take place at any time
prior to the Termination Date as determined by the Company and the Placement Agent, with respect to subscriptions accepted prior
to the Termination Date (each such closing, together with the Initial Closing, being referred to as a “Closing”).
The last Closing of the Offering, occurring on or prior to the Termination Date, shall be referred to as the “Final Closing”.
Any subscription documents or funds received after the Final Closing will be returned, without interest or deduction. In the event
that the any Closing does not occur prior to the Termination Date, all amounts paid by the Subscriber shall be returned to the
Subscriber, without interest or deduction. The Subscriber may revoke its subscription and obtain a return of the subscription
amount paid to the Company’s bank account at any time before the date of the Initial Closing by providing written notice
to the Placement Agent and the Company as provided in Section 6.1 below. Upon receipt of a revocation notice from the Subscriber
prior to the date of the Initial Closing, all amounts paid by the Subscriber shall be returned to the Subscriber, without interest
or deduction. The Subscriber may not revoke this subscription or obtain a return of the subscription amount paid to the Escrow
Agent on or after the date of the Initial Closing. Any subscription received after the Initial Closing but prior to the Termination
Date shall be irrevocable. Subscriber acknowledges that funds from any Closing will be held in a control account and will not
be able to be used by the Company without the consent of the Investor Representative.

 

    10

     

    

 

3.3
The minimum purchase that may be made by any prospective investor shall be $100,000. Subscriptions for investment below the minimum
investment may be accepted at the discretion of the Placement Agent and the Company. The Company and the Placement Agent reserve
the right to reject any subscription made hereby, in whole or in part, in their sole discretion. The Company’s agreement
with each Subscriber is a separate agreement and the sale of the Securities to each Subscriber is a separate sale. The Placement
Agent and the Company may agree to increase the Maximum Offering amount up to $2,000,000 without prior notice to the Subscribers.

 

3.4
All funds shall be deposited in the account identified in Section 1.1 hereof.

 

3.5
Certificates representing the Preferred Stock purchased by the Subscriber pursuant to this Subscription Agreement will be prepared
for delivery to the Subscriber as soon as practicable following the Closing (but in no event later than seven (7) days after a
Closing) at which such purchase takes place. The Subscriber hereby authorizes and directs the Company to deliver the certificates
representing the Securities purchased by the Subscriber pursuant to this Subscription Agreement directly to the Subscriber’s
residential or business or brokerage house address indicated on the signature page hereto.

 

3.6
The Company’s agreement with each Subscriber is a separate agreement and the sale of Securities to each Subscriber is a
separate sale.

 

IV.
CONDITIONS TO OBLIGATIONS OF THE SUBSCRIBER

 

4.1
The Subscriber’s obligation to purchase the Securities at the Closing at which such purchase is to be consummated is subject
to the fulfillment on or prior to such Closing of the following conditions, which conditions may be waived at the option of each
Subscriber to the extent permitted by law:

 

(a)
Representations and Warranties; Covenants. The representations and warranties made by the Company in Section 2 hereof
qualified as to materiality shall be true and correct at all times prior to and on the Closing Date(s), except to the extent any
such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be
true and correct as of such earlier date, and, the representations and warranties made by the Company in Section 2 hereof not
qualified as to materiality shall be true and correct in all material respects at all times prior to and on the Closing Date,
except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation
or warranty shall be true and correct in all material respects as of such earlier date. All covenants, agreements and conditions
contained in this Subscription Agreement to be performed by the Company on or prior to the date of such Closing shall have been
performed or complied with in all material respects.

 

    11

     

    

 

(b) No Legal Order Pending. There shall not then be in effect any legal or other order enjoining or restraining the transactions
contemplated by this Subscription Agreement.

 

(c) No Law Prohibiting or Restricting Such Sale. There shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person, which shall not have been obtained, to issue the Securities (except
as otherwise provided in this Subscription Agreement).

 

(d) Required Consents. The Company shall have obtained any and all consents, permits, approvals, registrations and waivers
necessary or appropriate for consummation of the purchase and sale of the Securities and the consummation of the other transactions
contemplated by the Offering Materials, all of which shall be in full force and effect.

 

(e) Adverse Changes. As of the date of execution of this Subscription Agreement, no event or series of events shall have occurred
that reasonably could have or result in a Material Adverse Effect.

 

(f) Blue
Sky. The Company shall have completed qualification for the Securities under applicable Blue Sky laws.

 

(g) Accounts
Payable. The Company shall have resolved all accounts payable on such terms acceptable to the Investor.

 

(h)
Conditions Precedent. As of the date of the Memorandum, all conditions precedent are completed for the commencement of the
Offering.

 

V.
COVENANTS OF THE COMPANY

 

5.1
Listing of Securities. The Company agrees, (i) if the Company applies to have the Common Stock traded on any other trading
market and (ii) it will take all action reasonably necessary to continue the listing and trading of its Common Stock on a trading
market and will comply in all material respects with the Company’s reporting, filing and other obligations under the bylaws
or rules of the trading market.

 

    12

     

    

 

5.2
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement
securities. If a replacement certificate or instrument evidencing any securities is requested due to a mutilation thereof, the
Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

5.3
Furnishing of Information. As long as Subscriber owns Securities, if the Company is not required to file reports pursuant
to the Exchange Act, it will prepare and furnish to Subscriber and make publicly available in accordance with Rule 144(c) such
information as is required for the Subscribers to sell the Securities under Rule 144. The Company further covenants that it will
take such further action as any holder of Securities may reasonably request, to the extent required from time to time to enable
such person to sell such Securities without registration under the Securities Act within the requirements of the exemption provided
by Rule 144.

 

5.4
Securities Laws; Publicity. The Company shall, by 8:30 a.m. (New York City time) on the fourth Trading Day immediately
following a Closing hereunder, issue a Current Report on Form 8-K disclosing the material terms of the transactions contemplated
hereby and including the Offering Materials as exhibits thereto. The Company shall not publicly disclose the name of Subscriber,
or include the name of any Subscriber in any filing with the Commission or any regulatory agency or trading market, without the
prior written consent of Subscriber, except: (a) as required by federal securities law in connection with (i) any registration
statement contemplated by this Subscription Agreement and (ii) the filing of final Offering Materials (including signature pages
thereto) with the SEC and (b) to the extent such disclosure is required by law, in which case the Company shall provide the Subscriber
with prior notice of such disclosure permitted under this clause (b).

 

5.5
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of the Subscriber. The Company shall take such action as the Company shall
reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Subscriber
at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide
evidence of such actions promptly upon request of any Subscriber.

 

5.6
Use of Proceeds. Except as set forth in the Memorandum, the Company shall not use the net proceeds from the sale of the
Securities hereunder for the redemption of any Common Stock or Common Stock equivalents. The Company acknowledges that $100,000
will be held in a segregated account until Directors and Officer’s Insurance is obtained by the Company. Such funds will
be released by the Company upon acquisition of such insurance.

 

    13

     

    

 

5.7
Follow-On Investment. For a period of one year from the date of Final Closing, Subscribers holding at least a majority
of the Preferred Stock outstanding from time to time shall have the right to cause the Corporation to sell for cash to such Subscribers
on a pro rata basis up to an aggregate of $1,000,000 of Common Stock in one or more transactions at a 10% discount to the
average closing price of the Common Stock (as reported for consolidated transactions with respect to securities listed on the
principal national securities exchange on which the Common Stock is listed or admitted to trading or, if the Common Stock is not
listed or admitted to trading on any national securities exchange, then in the over-the-counter market, as reported on any tier
maintained by the OTC Markets Group, Inc.) for the thirty (30) consecutive trading days immediately prior to (and including) the
Friday preceding the the date of such purchase or purchases. The Holders may exercise such right by delivering in accordance with
the notice provisions of this Subscription Agreement a written notice thereof to the Corporation specifying the amount of Common
Stock which the Holders intend to purchase. The Corporation and the Holders shall cooperate to close such sale as soon as reasonably
practical after receipt by the Corporation of such notice. Such sale shall be on terms and conditions customary for transactions
of this type.

 

5.8
Appointment of Directors.

 

(a)
At any time on or after the Initial Closing and until the Company’s 2019 annual meeting of stockholders, the
Subscribers, jointly and severally, shall have the exclusive right, voting separately as a class, to elect up to six (6)
directors (each director, an “Investor Director”). A Preferred Director shall be elected by the affirmative vote
of 50% of the Securities then outstanding (the “Required Holders”) either at meetings of shareholders at which
directors are elected, a special meeting of holders of Preferred Stock, if outstanding, or by written consent without a
meeting in accordance with the Nevada Revised Statutes. A Preferred Director so elected shall serve for a term of one year
and until his successor is elected and qualified. Any vacancy in the position of a Director may be filled only by the
affirmative vote of the Required Holders. A Preferred Director may, during his or her term of office, be removed at any time,
with or without cause, by and only by the affirmative vote, at a special meeting of holders of Preferred Stock called for
such purpose, or the written consent, of the Required Holders. Any vacancy created by such removal may also be filled at such
meeting or by such consent for the remainder of such initial one year term.

 

(b)
At any time on or after the Initial Closing and until the Company’s 2019 annual meeting of stockholders, International
Infusion LP (“Infusion”) shall have the right to elect up to three (3) directors (each director, an
“Infusion Director”). An Infusion Director shall be elected by Infusion either at meetings of shareholders at
which directors are elected, or by written consent without a meeting in accordance with the Nevada Revised Statutes. An
Infusion Director so initially elected shall serve for a term of one year and until his successor is elected and qualified.
Any vacancy in the position of an Infusion Director may be filled only by the affirmative vote of Infusion. An Infusion
Director may, during his or her term of office, be removed at any time, with or without cause. Any vacancy created by such
removal may also be filled by Infusion for the remainder of such initial one year term.

 

    14

     

    

 

5.9 Corporate
Governance. The Company shall use commercially reasonable efforts to increase the number of members on its Board of
Directors to nine (9) members and for as long as Subscribers hold Securities, the Company shall not increase the number
of members on the Board of Directors unless such increase is required under applicable rules and regulations of an national
securities exchange so a majority of the members on its Board of Directors shall be considered “independent
directors” within the meaning of the rules of such exchange in connection with an up-listing of the Company’s
Common Stock.

 

5.10 Stockholder
Approval.  As soon as practicable after the Final Closing, the Company shall use commercially
reasonable efforts to take all necessary actions and to obtain such approvals of the Company’s stockholders as may be
required to increase the Company’s authorized shares of Common Stock such that the Company can issue all of the shares
of Common Stock issuable upon completion of the restructuring and undertake a reverse stock split at such ratio where the
number of shares of Common Stock outstanding after consummation of such reverse stock split shall be approximately 15,000,000
shares (the “Reverse Split”) before the conversion of the Series A Convertible Preferred securities of the
Offering, all in accordance with the Nevada Revised Statutes (the “Stockholder Approval”).  The Company
shall furnish to each Buyer and its legal counsel promptly (but in no event less than one (1) business days) before the same
is filed with the SEC, one copy of the proxy or information statement and any amendment thereto, and shall deliver to each
Buyer promptly each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of
correspondence from the SEC or the staff of the SEC, in each case relating to such proxy or information statement (other than
any portion thereof which contains information for which the Company has sought confidential
treatment).  

 

5.11 Participation
in Future Financing.

 

(a)
From the date hereof until the consummation of the Reverse Split, upon any issuance by the Company of Common Stock or Common
Stock Equivalents (as defined in the Certificate of Designations) for cash consideration, indebtedness or a combination of
units thereof (a “Subsequent Financing”), each Qualifying Purchaser (as defined below) shall have the
right to participate in up to an amount of the Subsequent Financing equal to 50% of the Subsequent Financing(the
“Participation Maximum”) on the same terms, conditions and price provided for in the Subsequent Financing.
For purposes herein, “Qualifying Purchaser” means a Purchaser with a Subscription Amount of at least
$150,000. 

 

(b)
Between the time period of 4:00 pm (New York City time) and 6:00 pm (New York City time) on the Trading Day immediately
prior to the Trading Day of the expected announcement of the Subsequent Financing (or, if the Trading Day of the expected
announcement of the Subsequent Financing is the first Trading Day following a holiday or a weekend (including a holiday
weekend), between the time period of 4:00 pm (New York City time) on the Trading Day immediately prior to such holiday or
weekend and 2:00 pm (New York City time) on the day immediately prior to the Trading Day of the expected announcement of the
Subsequent Financing), the Company shall deliver to each Qualifying Purchaser a written notice of the Company’s
intention to effect a Subsequent Financing (a “Subsequent Financing Notice”), which notice shall describe
in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder
and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term
sheet and transaction documents relating thereto as an attachment.

 

    15

     

    

 

(c)
Any Qualifying Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by
6:30 am (New York City time) on the Trading Day following the date on which the Subsequent Financing Notice is delivered to
such Qualifying Purchaser (the “Notice Termination Time”) that such Qualifying Purchaser is willing to
participate in the Subsequent Financing, the amount of such Qualifying Purchaser’s participation, and representing and
warranting that such Qualifying Purchaser has such funds ready, willing, and available for investment on the terms set forth
in the Subsequent Financing Notice. If the Company receives no such notice from a Qualifying Purchaser as of such Notice
Termination Time, such Qualifying Purchaser shall be deemed to have notified the Company that it does not elect to
participate in such Subsequent Financing.

 

(d)
If, by the Notice Termination Time, notifications by the Qualifying Purchasers of their willingness to participate in the
Subsequent Financing (or to cause their designees to participate) is, in the aggregate, less than the total amount of the
Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing on the terms and with
the Persons set forth in the Subsequent Financing Notice.

 

(e)
If, by the Notice Termination Time, the Company receives responses to a Subsequent Financing Notice from Qualifying
Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such Qualifying Purchaser
shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation Maximum.  “Pro
Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a
Qualifying Purchaser participating under this Section and (y) the sum of the aggregate Subscription Amounts of Securities
purchased on the Closing Date by all Qualifying Purchasers participating under this Section

 

(f)
The Company must provide the Qualifying Purchasers with a second Subsequent Financing Notice, and the Qualifying Purchasers will
again have the right of participation set forth above in this Section, if the definitive agreement related to the initial Subsequent
Financing Notice is not entered into for any reason on the terms set forth in such Subsequent Financing Notice within two (2)
Trading Days after the date of delivery of the initial Subsequent Financing Notice.

 

(g)
The Company and each Qualifying Purchaser agree that, if any Qualifying Purchaser elects to participate in the Subsequent
Financing, the transaction documents related to the Subsequent Financing shall not include any term or provision whereby such
Qualifying Purchaser shall be required to agree to any restrictions on trading as to any of the Securities purchased
hereunder or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or
in connection with, this Subscription Agreement, without the prior written consent of such Qualifying Purchaser. In addition,
the Company and each Qualifying Purchaser agree that, in connection with a Subsequent Financing, the transaction documents
related to the Subsequent Financing shall include a requirement for the Company to issue a widely disseminated press release
by 9:30 am (New York City time) on the Trading Day of execution of the transaction documents in such Subsequent Financing
(or, if the date of execution is not a Trading Day, on the immediately following Trading Day) that discloses the material
terms of the transactions contemplated by the transaction documents in such Subsequent Financing.

 

    16

     

    

 

(h)
Notwithstanding anything to the contrary in this Section and unless otherwise agreed to by such Qualifying Purchaser, the
Company shall either confirm in writing to such Qualifying Purchaser that the transaction with respect to the Subsequent
Financing has been abandoned or shall publicly disclose its intention to issue the securities in the Subsequent Financing, in
either case in such a manner such that such Qualifying Purchaser will not be in possession of any material, non-public
information, by 9:30 am (New York City time) on the second (2nd) Trading Day following date of delivery of the Subsequent
Financing Notice. If by 9:30 am (New York City time) on such second (2nd) Trading Day, no public disclosure regarding a
transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such
transaction has been received by such Qualifying Purchaser, such transaction shall be deemed to have been abandoned and such
Qualifying Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the
Company or any of its Subsidiaries.

 

(i)   Notwithstanding the foregoing, this Section shall not apply in respect of an Exempt Issuance. For purposes of this Section, “Exempt
Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants
of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of
the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for
services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder
and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the
date of this Subscription Agreement including for any warrants issued to the Placement Agent, and (c) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the directors of the Company, which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and
shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in
which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is
investing in securities.

 

VI   REGISTRATION
RIGHTS

 

6.1
Definitions. As used in this Section, the following terms shall have the following meanings:

 

“Effectiveness
Date” means, with respect to the Initial Registration Statement required to be filed hereunder, as soon as commercially
practicable following the filing of the Initial Registration Statement, and with respect to any additional Registration Statements
which may be required pursuant to Section 5.3(c), as soon as commercially practicable following the date on which an additional
Registration Statement is required to be filed hereunder.

 

“Effectiveness
Period” means the period from the Effectiveness Date of a Registration Statement through the date that all Registrable
Securities covered by such Registration Statement have been sold, or may be sold without volume restrictions pursuant to Rule
144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable
to the Company’s transfer agent and the affected Holders.

 

    17

     

    

 

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to this Subscription Agreement.

 

“Legal
Counsel” means one (1) counsel as designated by a majority of the holders of the Registrable Securities.

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments
and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to
be incorporated by reference in such Prospectus.

 

“Registrable
Securities” means (a) all of the shares of Common Stock issuable upon exchange of the Preferred Stock, (b) any shares
of Common Stock issuable upon exercise of any warrants issued to the Placement Agent (assuming on the date of determination the
warrants are exercised in full without regard to any exercise limitations therein) and (c) any securities issued or issuable upon
any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; provided,
however, that the Company shall not be required to maintain the effectiveness, or file another Registration Statement hereunder
with respect to any Registrable Securities that are (i) not subject to the current public information requirement under Rule 144
and that are eligible for resale without volume or manner-of-sale restrictions without current public information pursuant to
Rule 144 promulgated by the Commission or (ii) not required to be registered in reliance upon the exemption in Section 4(1) under
the Securities Act, in either case pursuant to a written opinion letter to such effect, addressed, delivered and acceptable to
the affected Subscribers.

 

“Registration
Statement” means any registration statement required to be filed hereunder pursuant to Section 5.2(a) and any additional
registration statements contemplated by Section 5.3(c), including (in each case) the Prospectus, amendments and supplements to
any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in any such registration statement.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“SEC
Guidance” means (i) any publicly-available written or oral guidance, comments, requirements or requests of the Commission
staff and (ii) the Securities Act.

 

    18

     

    

 

6.2
 Demand Registration.

 

(a)Beginning
on the six month anniversary of the Final Closing, on or prior to the sixtieth (60th) calendar day after the date of receipt of
written demand from Subscribers holding at least 51% of Registrable Securities, the Company shall prepare and file with the Commission
a Registration Statement covering the resale of all of the Registrable Securities that are not then registered on an effective
Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Subject to the terms of this Subscription
Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Subscription Agreement to
be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than
the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective during
the Effectiveness Period.

 

(b)Notwithstanding
the registration obligations set forth in Section 6.2(a), if the Commission informs the Company that all of the Registrable Securities
cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file
amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities
permitted to be registered by the Commission, provided, however, that, prior to filing such amendment, the Company
shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities
in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.

 

(c)Notwithstanding
any other provision of this Subscription Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number
of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable
Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities
to be registered on such Registration Statement will be reduced as follows: First, the Company shall reduce or eliminate any securities
to be included other than Registrable Securities; and Second, the Company shall reduce or eliminate any securities issued to the
Placement Agent. 

 

(d)In
the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its best
efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-1 or such other form available to register for resale
those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended. Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder
as any Underwriter without the prior written consent of such Holder.

 

    19

     

    

 

6.3   Piggy
Back Registration.

 

(a)
At any time the Registrable Securities are owned by a Subscriber and there is not an effective registration statement
covering all of the Registrable Securities, and if the Company shall determine to prepare and file with the SEC a
registration statement relating to an offering for its own account or the account of others under the Act, of any of its
equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Act) or their then equivalents, relating
to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities
issuable in connection with the Company’s stock option or other employee benefit plans, then the Company shall deliver
to each Subscriber a written notice of such determination and, if within fifteen (15) days after the date of the delivery of
such notice, any such Subscriber shall so request in writing, the Company shall include in such registration statement all or
any part of such Registrable Securities such Subscriber requests to be registered; provided, however, that Registrable
Securities will not be included if the underwriter(s) associated with the offering which is the subject of the registration
statement believes, in good faith, that the inclusion of such Registrable Securities will have an adverse effect on the sale
of the securities for which such registration statement was filed, and further provided, however, that the
Company shall not be required to register any Registrable Securities pursuant to this Section 6.2 that are eligible
for resale pursuant to Rule 144 promulgated by the SEC pursuant to the Act or that are the subject of a then effective
registration statement. If any SEC Guidance sets forth a limitation on the number of securities permitted to be registered on
a particular registration statement (and notwithstanding that the Company used diligent efforts to advocate with the SEC for
the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Subscriber
as to its Registrable Securities, the number of Registrable Securities to be registered on such registration statement will
be reduced on a pro rata basis with such other securities being registered on the applicable registration after
as full an allocation as possible has been afforded for the securities for which the registration statement has been
filed.

 

(b)
Reserved.

 

(c)
Subject to the terms and conditions of this Subscription Agreement, Subscribers shall have the right to select Legal Counsel
to review and oversee, solely on its behalf, any Registration Statement pursuant to this Subscription Agreement, if such
Registration Statement is filed. The Company shall also reimburse Legal Counsel for its documented fees and disbursements in
connection with registration, filing or qualification pursuant to this Subscription Agreement which amount shall be limited
to $5,000.

 

    20

     

    

 

6.4 Registration
Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

 

(a)
Not less than five (5) Trading days prior to the filing of each Registration Statement and not less than one (1) Trading day
prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be
incorporated or deemed to be incorporated therein by reference), the Company shall (i) furnish to Legal Counsel copies of the
Registration Statement proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by
reference) will be subject to the review of Legal Counsel; and (ii) cause its officers and directors, counsel and independent
registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of Legal Counsel,
to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registration
Statement or any such Prospectus or any amendments or supplements thereto to which the Subscribers of a majority of the
Registrable Securities or Legal Counsel shall reasonably object in good faith, provided that, the Company is notified of such
objection in writing no later than three (3) Trading days after Legal Counsel has been so furnished a copy of a Registration
Statement or one (1) Trading day after Legal Counsel has been so furnished copies of any related Prospectus or amendments or
supplements thereto. Each Subscriber agrees to furnish to the Company a completed questionnaire in the form attached to this
Subscription Agreement as Annex B (a “Selling Stockholder Questionnaire”) on a date that is not
less than two (2) Trading days prior to the Filing Date or by the end of the fourth (4th) Trading day following
the date on which such Subscriber receives draft materials in accordance with this Section.

 

(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement
and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective
as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such
additional Registration Statements in order to register for resale under the Securities Act all of the Registrable
Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to
the terms of this Subscription Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii)
respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Subscriber’s true and complete
copies of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company may
excise any information contained therein which would constitute material non-public information as to any Subscriber which
has not executed a confidentiality agreement with the Company), and (iv) comply in all material respects with the provisions
of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a
Registration Statement during the applicable period in accordance (subject to the terms of this Subscription Agreement) with
the intended methods of disposition by the Subscribers thereof set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented.

 

    21

     

    

 

(c)
Notify the Subscribers of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi)
hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as
promptly as reasonably possible (and, in the case of (i)(A) below, not less than one trading day prior to such filing) and
(if requested by any such Person) confirm such notice in writing no later than one Trading day following the day (i)(A) when
a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed,
(B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and
whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement
or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other
federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for
additional information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any
stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the
initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any
jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or
passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or
any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or
other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading and (vi) of the occurrence
or existence of any pending corporate development with respect to the Company that the Company believes may be material and
that, in the determination of the Company, makes it not in the best interest of the Company to allow continued
availability of a Registration Statement or Prospectus, provided that, any and all of such information shall remain
confidential to each Subscriber until such information otherwise becomes public, unless disclosure by a Subscriber is
required by law.

 

(d)
Use its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order
stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or
exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable
moment.

 

(e)
Furnish to Legal Counsel, without charge, at least one conformed copy of each such Registration Statement and each amendment
thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by
reference to the extent requested by such person, and all exhibits to the extent requested by such Person (including those
previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided,
that any such item which is available on the EDGAR system need not be furnished in physical form.

 

(f)
Subject to the terms of this Subscription Agreement, the Company hereby consents to the use of such Prospectus and each amendment
or supplement thereto by each of the selling Subscribers in connection with the offering and sale of the Registrable Securities
covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section
3(c).

 

(g)
The Company, in conjunction with a Placement Agent, shall effect a filing with respect to the public offering contemplated
by the Registration Statement (an “Issuer Filing”) with the Financial Industry Regulatory Authority, Inc.
(“FINRA”) Corporate Financing Department pursuant to FINRA Rule 5110 within one Trading Day of the date
that the Registration Statement is first filed with the Commission and pay the filing fee required by such Issuer Filing. The
Company, in conjunction with a Placement Agent, shall use commercially reasonable efforts to pursue the Issuer Filing until
the FINRA issues a letter confirming that it does not object to the terms of the offering contemplated by the Registration
Statement. A copy of the Issuer Filing and all related correspondence with respect thereto shall be provided to a Placement
Agent.

 

(h)
Prior to any resale of Registrable Securities by a Subscriber, use its commercially reasonable efforts to register or
qualify or cooperate with the selling Subscribers in connection with the registration or qualification (or exemption from the
Registration or qualification) of such Registrable Securities for the resale by the Subscriber under the securities or Blue
Sky laws of such jurisdictions within the United States as any Subscriber reasonably requests in writing, to keep each
registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other
acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by
each Registration Statement; provided, that, the Company shall not be required to qualify generally to do business in any
jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is
not then so subject or file a general consent to service of process in any such jurisdiction.

 

(i)
If requested by a Subscriber, cooperate with such Subscribers to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be delivered to a transferee pursuant to an effective Registration
Statement, which certificates shall be free, to the extent permitted by the Subscription Agreement, of all restrictive
legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such
Subscriber may request.

 

    22

     

    

 

(j)
The Company will, as promptly as reasonably possible under the circumstances taking into account the Company’s good faith
assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that,
as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Subscribers in accordance with clauses (iii) through (vi)
of Section 6.3(c) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then
the Subscribers shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus
may be resumed as promptly as is practicable.

 

(k)
Comply with all applicable rules and regulations of the Commission.

 

(l)   The Company may require each selling Subscriber to furnish to the Company a certified statement as to the number of shares of
Common Stock beneficially owned by such Subscriber and, if required by the Commission, the natural persons thereof that have voting
and dispositive control over the shares. During any periods that the Company is unable to meet its obligations hereunder with
respect to the registration of the Registrable Securities solely because any Subscriber fails to furnish such information within
three Trading days of the Company’s request, any liquidated damages that are accruing at such time as to such Subscriber
only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Subscriber
only, until such information is delivered to the Company.

 

6.5.
Registration Expenses. All fees and expenses incident to the performance of or compliance with Section by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. In no event
shall the Company be responsible for any broker or similar commissions of any Subscriber or, except to the extent provided for
in the Offering Materials, any legal fees (except per section 6.3(c)) or other costs of the Subscribers.

 

VII.
MISCELLANEOUS

 

7.1
Any notice or other communication given hereunder shall be deemed sufficient if in writing and sent by registered or certified
mail, return receipt requested, or delivered by hand against written receipt therefor, addressed as follows:

 

if
to the Company, to it at:

 

Avant
Diagnostics, Inc.

1050
30th Street NW Suite 107

Washington,
D.C. 20007

Attn:
Secretary

 

With
a copy to (which shall not constitute notice):

 

Sheppard,
Mullin, Richter & Hampton LLP

30
Rockefeller Plaza, 39th Floor

New
York, NY 10112

Attn: Stephen A. Cohen, Esq.

 

if
to the Subscriber, to the Subscriber’s address indicated on the signature page of this Subscription Agreement.

 

    23

     

    

 

7.2
Notices shall be deemed to have been given or delivered on the date of receipt. Except as otherwise provided herein, this Subscription
Agreement shall not be changed, modified or amended except by a writing signed by the parties to be charged, and this Subscription
Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged.
No waiver of any default with respect to any provision, condition or requirement of this Subscription Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or
requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right.

 

7.3
This Subscription Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs,
legal representatives, successors and assigns. The Company may not assign this Subscription Agreement or any rights or obligations
hereunder without the prior written consent of Subscriber (other than by merger). Subscriber may assign any or all of its rights
under this Subscription Agreement to any person to whom Subscriber assigns or transfers any Securities, provided that such transferee
agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Offering Materials and this
Subscription Agreement.

 

7.4
The Offering Materials, together with the exhibits and schedules thereto, contain the entire understanding of the parties with
respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

7.5
Upon the execution and delivery of this Subscription Agreement by the Subscriber and the Company, this Subscription Agreement
shall become a binding obligation of the Subscriber with respect to the purchase of Securities as herein provided, subject, however,
to the right hereby reserved by the Company to enter into the same agreements with other Subscriber and to reject any subscription,
in whole or in part, provided the Company returns to Subscriber any funds paid by Subscriber with respect to such rejected subscription
or portion thereof, without interest or deduction.

 

7.6
All questions concerning the construction, validity, enforcement and interpretation of the Offering Materials shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Subscription Agreement and any other Offering Materials (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in
the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Offering Materials), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding.

 

    24

     

    

 

7.7
In order to discourage frivolous claims the parties agree that unless a claimant in any proceeding arising out of this Subscription
Agreement succeeds in establishing his claim and recovering a judgment against another party (regardless of whether such claimant
succeeds against one of the other parties to the action), then the other party shall be entitled to recover from such claimant
all of its/their reasonable legal costs and expenses relating to such proceeding and/or incurred in preparation therefor.

 

7.8
The holding of any provision of this Subscription Agreement to be invalid or unenforceable by a court of competent jurisdiction
shall not affect any other provision of this Subscription Agreement, which shall remain in full force and effect. If any provision
of this Agreement shall be declared by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced
in whole or in part, such provision shall be interpreted so as to remain enforceable to the maximum extent permissible consistent
with applicable law and the remaining conditions and provisions or portions thereof shall nevertheless remain in full force and
effect and enforceable to the extent they are valid, legal and enforceable, and no provisions shall be deemed dependent upon any
other covenant or provision unless so expressed herein.

 

7.9
The representations, warranties, covenants and agreements contained in this Agreement, shall survive the Closing of the transactions
contemplated by this Subscription Agreement and the delivery of the Securities for the applicable statute of limitations.

 

7.10 
It is agreed that a waiver by either party of a breach of any provision of this Subscription Agreement shall not operate, or be
construed, as a waiver of any subsequent breach by that same party.

 

7.11 
The Company agrees to execute and deliver all such further documents, agreements and instruments and take such other and further
action as may be necessary or appropriate to carry out the purposes and intent of this Subscription Agreement.

 

7.12 
This Subscription Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of
which shall together constitute one and the same instrument. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

7.13 
Nothing in this Subscription Agreement shall create or be deemed to create any rights in any person or entity not a party to this
Subscription Agreement.

 

7.14 
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Subscriber
and the Company will be entitled to specific performance under this Subscription Agreement. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations described in this Subscription Agreement
and hereby agrees to waive in any action for specific performance of any such obligation the defense that a remedy at law would
be adequate.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    25

     

    

 

DOLLAR
SUBSCRIPTION __________ / $[1.00] = ______________ NUMBER OF SHARES OF PREFERRED STOCK

 

	 	 	 
	 	 	 
	Signature	 	Signature (if purchasing jointly)
	 	 	 
	 	 	 
	Name Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Title (if Subscriber is an Entity)	 	Title (if Subscriber is an Entity)
	 	 	 
	 	 	 
	Entity Name (if applicable)	 	Entity Name (if applicable)
	 	 	 
	 	 	 
	 	 	 
	Address	 	Address
	 	 	 
	 	 	 
	City, State and Zip Code	 	City, State and Zip Code
	 	 	 
	 	 	 
	Telephone-Business	 	Telephone-Business
	 	 	 
	 	 	 
	Telephone-Residence	 	Telephone-Residence
	 	 	 
	 	 	 
	Facsimile-Business	 	Facsimile-Business
	 	 	 
	 	 	 
	Facsimile-Residence	 	Facsimile-Residence
	 	 	 
	 	 	 
	Tax ID # or Social Security #	 	Tax ID # or Social Security #
	 	 	 
	 	 	 
	E-Mail Address	 	E-Mail Address

 

Name
in which securities should be issued:                                                                          

 

Dated:
              , 2018

 

This
Subscription Agreement is agreed to and accepted as of ________________, 2018.

 

	 	AVANT DIAGNOSTICS, INC.
	 	 	 
	 	By:	               
	 	Name:	 
	 	Title:	 

 

    26

     

    

 

CERTIFICATE OF SIGNATORY

 

(To
be completed if Securities are

being
subscribed for by an entity)

 

I,
____________________________, am the ____________________________ of __________________________________________ (the “Entity”).

 

I
certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Subscription Agreement
and to purchase and hold the Securities (and, upon issuance, the Underlying Shares), and certify further that the Subscription
Agreement has been duly and validly executed on behalf of the Entity and constitutes a legal and binding obligation of the Entity.

 

IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________, 20__

 

	 	
	 	(Signature)

 

    27

     

    

 

Exhibit
A

 

INVESTOR
QUESTIONNAIRE

 

AVANT
DIAGNOSTICS, INC.

 

For
Individual Investors Only

(All
individual investors must INITIAL where appropriate. 

Where
there are joint investorsboth parties must INITIAL):

 

	Initial
_______	I
certify that I have a “net worth” of at least $1 million either individually or through aggregating my individual
holdings and those in which I have a joint, community property or other similar shared ownership interest with my spouse. For
purposes of calculating net worth under this paragraph, (i) the primary residence shall not be included as an asset, (ii) to the
extent that the indebtedness that is secured by the primary residence is in excess of the fair market value of the primary residence,
the excess amount shall be included as a liability, and (iii) if the amount of outstanding indebtedness that is secured by the
primary residence exceeds the amount outstanding 60 days prior to the execution of this Subscription Agreement, other than as
a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability.

 

	Initial _______	I
certify that I have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse)
and expect my income (or joint income, as appropriate) to reach the same level in the current year.

 

For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
_______	The
                                         undersigned certifies that it is a partnership, corporation, limited liability company
                                         or business trust that is 100% owned by persons who meet either of the criteria for Individual
                                         Investors, above.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is a partnership, corporation, limited liability company
                                         or business trust that has total assets of at least $5 million and was not formed for
                                         the purpose of investing in Company.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is an employee benefit plan whose investment decision is
                                         made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and
                                         loan association, insurance company or registered investment adviser.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is an employee benefit plan whose total assets exceed $5,000,000
                                         as of the date of the Subscription Agreement.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is a self-directed employee benefit plan whose investment
                                         decisions are made solely by persons who meet either of the criteria for Individual Investors,
                                         above.

 

    A-1

     

    

 

	Initial
_______	The
                                         undersigned certifies that it is a U.S. bank, U.S. savings and loan association or other
                                         similar U.S. institution acting in its individual or fiduciary capacity.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is a broker-dealer registered pursuant to §15 of the
                                         Securities Exchange Act of 1934.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is an organization described in §501(c)(3) of the
                                         Internal Revenue Code with total assets exceeding $5,000,000 and not formed for the specific
                                         purpose of investing in Company.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is a trust with total assets of at least $5,000,000, not
                                         formed for the specific purpose of investing in Company, and whose purchase is directed
                                         by a person with such knowledge and experience in financial and business matters that
                                         he is capable of evaluating the merits and risks of the prospective investment.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is a plan established and maintained by a state or its
                                         political subdivisions, or any agency or instrumentality thereof, for the benefit of
                                         its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
_______	The
                                         undersigned certifies that it is an insurance company as defined in §2(a)(13) of
                                         the Securities Act of 1933, as amended, or a registered investment company.

 

 

 

 

 

 

 

 

 

 

 

Printed
Name of Subscriber (Individual OR Non-Individual Entity)

 

 

A-2Exhibit 10.2

 

EXCHANGE
AGREEMENT

 

This
EXCHANGE AGREEMENT (this “Agreement”) is made effective as of May 25, 2018 (the “Execution Date”)
by and among Avant Diagnostics, Inc., a Nevada corporation (the “Company”) and _______________ (the “Investor”).

 

RECITALS

 

WHEREAS,
the Company has previously issued to the Investor (i) certain Convertible Promissory Notes dated _________________, for an aggregate
principal amount of $__________ (collectively, the “2016 Notes”), (ii) certain Convertible Promissory Note
dated ______________, for an aggregate principal amount of $_________ (collectively, the “2017 Notes” and together
with the 2016 Notes, the “Existing Notes”), and (iii) warrants to purchase an aggregate of __________ shares
of common stock which were issued in connection with the 2017 Notes (the “Existing Warrants”) and (iii) common
stock purchase rights, for the purchase of an aggregate of _____________ shares of common stock (the “Existing Purchase
Rights” and together with the Existing Notes and the Existing Warrants, the “Existing Securities”);

 

WHEREAS,
the Company acknowledges that the Existing Notes are currently in default (collectively, the “Default”);

 

WHEREAS,
as of March 31, 2018, the aggregate principal amount plus all interest, penalties and other amounts which are due and payable
on the 2016 Notes and 2017 Notes is $_______ and $________ respectively (collectively, the “Owed Amount”);

 

WHEREAS,
the Company desires, and the Investor agrees, that the Investor exchange (the “Exchange”) the Existing Securities
(which have an outstanding balance equal to the Owed Amount) for (i) a promissory note in the aggregate principal amount of $47,259
(the “New Note”) (ii) _____ shares of series A convertible preferred stock having an aggregate value of $_____
and such rights and preferences in a certificate of designation as attached hereto as Exhibit A (the “Series A
Preferred Stock”) and (ii) ______ shares of series B convertible preferred stock having an aggregate value of $_____
and such rights and preferences in a certificate of designation as attached hereto as Exhibit B (the “Series B
Preferred Stock” and together with the New Note and the Series A Preferred Stock, the “New Securities”);

 

WHEREAS,
each of the New Securities, is intended to qualify as an exempted security under Section 3(a)(9) of the Securities Act of 1933,
as amended (the “Securities Act”).

 

NOW,
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

 

ARTICLE
I

THE
EXCHANGE

 

1.1  
Waiver of Existing Defaults. Subject to the terms hereof, Investor hereby irrevocably waives the defaults and breaches
that have resulted from the Default on or prior to the Execution Date as well as any penalties, interest or other amounts that
may have accrued under the Existing Notes after March 31, 2018. This waiver does not include any default or breach occurring after
the Execution Date should the Closing not occur.

 

1.2  Closing.
Subject to the terms and conditions set forth in this Agreement, the Company and the Investor shall exchange the Existing Securities
in consideration for the issuance of the New Securities. The closing of the Exchange and issuance of the New Securities (the “Closing”)
shall take place at the offices of the Company, on the date hereof or such other date as the parties shall agree (the “Closing
Date”).

 

1.3  
Exchange.

 

(a)  
Investor Obligations. At the Closing, the Investor shall deliver or promptly cause to be delivered to the Company (i) the
Existing Notes, (ii) the Existing Warrants, (iii) the Existing Purchase Rights and (iv) an executed copy of this Agreement.

 

    	 	-1-	 

     

    

 

(b)  
Company Obligations. At the Closing, the Company shall deliver or promptly cause to be delivered to the Investor (i) a
certificate representing the Series A Preferred Stock, (ii) a certificate representing the Series B Preferred Stock, (iii) the
New Note and (iv) an executed copy of this Agreement.

 

ARTICLE
II

REPRESENTATIONS
AND WARRANTIES

 

2.1  
Investor Representations and Warranties. The Investor hereby represents and warrants to the Company as follows on the Execution
Date and the Closing Date:

 

(a)  
Organization; Authority. The Investor, if not a natural person, is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization. The Investor has the requisite power and authority to enter into
and to consummate the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder. This Agreement
has been duly executed by the Investor, and when delivered by the Investor in accordance with the terms hereof, will constitute
the valid and legally binding obligation of the Investor, enforceable against it in accordance with its terms.

 

(b)  
Ownership of the Existing Securities. The Investor is the sole owner of the Existing Securities, free and clear of any
and all liens, claims and encumbrances of any kind. The Investor has not assigned any rights in the Existing Securities to any
party.

  

(c)  
Investment Intent. The Investor is acquiring the New Securities as principal for its own account for investment purposes
only and not with a view to or for distributing or reselling such New Securities or any part thereof, except pursuant to sales
that are exempt from the registration requirements of the Securities Act and/or sales registered under the Securities Act. The
Investor does not have any agreement or understanding, directly or indirectly, with any person or entity to distribute the New
Securities. Notwithstanding anything in this Section 2.1(c) to the contrary, by making the representations herein, the
Investor does not agree to hold the New Securities for any minimum or other specific term and reserves the right to dispose of
the New Securities at any time in accordance with or pursuant to a registration statement or an exemption from the registration
requirements under the Securities Act, subject to the lock-up restrictions set forth herein.

 

(d)  
Investor Status. At the time the Investor was offered the New Securities, it was, and at the date hereof it is, and on
the date of issuance of any Conversion Shares (as defined herein), it will be, an “accredited investor” as defined
in Rule 501(a) of Regulation D under the Securities Act. The Investor is not a broker-dealer.

 

(e)  
General Solicitation. The Investor is not acquiring the New Securities as a result of or subsequent to any advertisement,
article, notice or other communication regarding the New Securities published in any newspaper, magazine or similar media or broadcast
over television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(f)  
Reliance. The Investor understands and acknowledges that (i) the New Securities are being offered and sold to it without
registration under the Securities Act in a transaction that is exempt from the registration provisions of the Securities Act,
and (ii) the availability of such exemption depends in part on, and the Company will rely upon the accuracy and truthfulness
of, the foregoing representations, and the Investor hereby consents to such reliance.

 

(g)  
Brokers and Finders. The Investor has no knowledge of any person who will be entitled to or make a claim for payment of
any finder fee or other compensation as a result of the consummation of the transactions contemplated by this Agreement.

 

(h)  Experience.
Investor has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating
the merits and risks of the prospective investment in the New Securities, and has so evaluated the merits and risks of such investment.
Investor is able to bear the economic risk of an investment in the New Securities and, at the present time, is able to afford
a complete loss of such investment.

 

(i)  Access
to Information. Such Investor acknowledges that it has had the opportunity to review this Agreement (including all exhibits
and schedules thereto) and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
answers from, representatives of the Company concerning the terms and conditions of the New Securities; (ii) access to information
about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient
to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to
the investment.

 

    	 	-2-	 

     

    

 

(j)  [Lock-Up
Agreement for New Securities. Each Conversion Share received in connection with the conversion of the New Securities shall
be subject to a lock-up beginning on the date hereof and ending on the nine (9) month anniversary of the date the Company’s
laboratory is open for business (the "Lockup Period"). During the Lockup Period, the Investor may not, directly
or indirectly, (i) offer, sell, offer to sell, contract to sell, hedge, pledge, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase or sell (or announce any offer, sale, offer of
sale, contract of sale, hedge, pledge, sale of any option or contract to purchase, purchase of any option or contract of sale,
grant of any option, right or warrant to purchase or other sale or disposition), or otherwise transfer or dispose of (or enter
into any transaction or device that is designed to, or could be expected to, result in the disposition by any person at any time
in the future), any Common Stock acquired pursuant to this Agreement, or hereafter acquired or (ii) enter into any swap or other
agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership
of any Common Stock, whether or not any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery
of any Common Stock. For the first one hundred and eighty (180) days after termination of the Lockup Period, the Holder shall
be subject to a daily liquidation limit for any sales of Common Stock equal to two and a half percent (2.5%) of the average trading
volume of the Company’s Common Stock for the prior five (5) trading days, but excluding the date of sale (the “Leakout
Limitation”). For any sale proposed by Investor in excess of the Leakout Limitation, the Company will have (a) a right
of first refusal for a period of 15 Business Days after receipt of written notice of such sale from the Investor, to purchase
such shares of Common Stock subject to the Leakout Limitation at a price equal to the average closing price per share of the Company’s
Common Stock for the prior five (5) trading days prior to such notice, and (b) if not purchased by the Company, the Company will
have approval rights of the counter party proposed by Investor for the sale of any such securities, such approval in the Company’s
sole and absolute discretion. For purposes of clarity, any proposed sale below the Leakout Limitation shall not require any consent
or approval of the Company. The terms of this provision shall convey to any subsequent holder of the Common Stock issued pursuant
to the New Securities. Investor agrees that it shall not transfer or dispose of any shares of Common
Stock (other than pursuant to this Agreement) unless and until the proposed transferee(s) has agreed in writing to be bound by
this Section with respect to the shares of Common Stock acquired by such transferee. No transfer in violation of the preceding
sentence shall be of any force or effect, and no such transfer shall be made or recorded on the books of Company. Investor acknowledges
that its covenants in this Section are a material inducement for Company to enter into this Agreement and to consummate this transaction.]

 

(k)  Investor
understands that the Company is not current in its reporting obligations with the SEC and that the Company was previously was
a “shell company” as defined in Rule 12b-2 under the Exchange Act. Pursuant to Rule 144(i), securities issued by a
current or former shell company that otherwise meet the holding period and other requirements of Rule 144 nevertheless cannot
be sold in reliance on Rule 144 until one year after the Company (a) is no longer a shell company; and (b) has filed current
“Form 10 information“ (as defined in Rule 144(i)) with the SEC reflecting that it is no longer a shell company, and
provided that at the time of a proposed sale pursuant to Rule 144, the Company is subject to the reporting requirements of Section
13 or 15(d) of the Exchange Act and has filed all reports and other materials required to be filed by Section 13 or 15(d) of the
Exchange Act, as applicable, during the preceding 12 months (or for such shorter period that the issuer was required to file such
reports and materials), other than Form 8-K reports. As a result, the restrictive legends on certificates for the New Securities
and the Conversion Shares, cannot be removed after the expiration of any lock-up restriction except in connection with an actual
sale meeting the foregoing requirements or pursuant to an effective registration statement.

 

2.2  
Company Representations and Warranties. The Company hereby makes the following representations and warranties to each Investor
on the Execution Date and on the Closing Date:

 

(a)  
Organization and Qualification. The Company is a corporation incorporated, validly existing and in good standing under
the laws of the State of Nevada, with the requisite corporate power and authority to own and use its properties and assets and
to carry on its business as currently conducted. The Company is duly qualified as a foreign corporation to do business and is
in good standing in every jurisdiction where the nature of the business it conducts makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of the New Securities, or this Agreement, (ii) a
material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis
its obligations under the New Securities, or this Agreement (any of (i), (ii) or (iii), a “ Material Adverse Effect
”).

 

    	 	-3-	 

     

    

 

(b)  
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and to issue the New Securities and the shares of common stock issuable upon conversion
of the Series A Preferred Stock and the Series B Preferred Stock (collectively, the Conversion Shares”) in accordance with
the terms of the respective New Securities, and otherwise to carry out its obligations hereunder and thereunder. The execution,
delivery and performance of this Agreement and any other agreements and the consummation of the transactions contemplated hereby
and thereby have been duly authorized by the Company’s Board of Directors, and no further consent or authorization of the
Company, its Board of Directors (including any committee thereof) or any class of the Company’s stockholders is required.
This Agreement and the New Securities have been duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligations of the Company enforceable against the Company, in accordance with their
terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

  

(c)  
Issuance of the New Securities. The Series A Preferred Stock is duly authorized and, when issued and paid for in accordance
with this Agreement, will be duly and validly issued, fully paid and nonassessable. The Series B Preferred Stock is duly authorized
and, when issued and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable.
The Conversion Shares, when issued in accordance with the terms of the New Securities, will be validly issued, fully paid and
nonassessable, free and clear of all liens imposed by the Company other than restrictions on transfer provided for in the New
Securities or under applicable securities laws.

 

(d)  
No Conflicts. The execution, delivery and performance of this Agreement, and the New Securities and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for
issuance, as applicable, of the Conversion Shares will not, (i) result in a violation of the articles of incorporation of the
Company, as amended (the “Articles of Incorporation”) or the bylaws of the Company (the “Bylaws”)
or (ii) result in a violation of any law, rule, regulation, order, judgment or decree (including United States federal and state
securities laws and regulations and rules or regulations of any self-regulatory organizations to which either the Company or its
securities are subject) applicable to the Company or by which any property or asset of the Company is bound or affected. The Company
is not in violation of its Articles of Incorporation, Bylaws or other organizational documents.

 

(e)  
Absence of Certain Changes. The Company has not taken any steps, and does not currently expect to take any steps, to seek
protection pursuant to any bankruptcy or receivership law nor does the Company have any knowledge or reason to believe that its
creditors intend to initiate involuntary bankruptcy proceedings with respect to the Company.

 

(f)  
Certain Fees. No fees or commissions (other than legal and accounting fees) will be payable by the Company to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by this Agreement.

 

ARTICLE
III

OTHER
COVENANTS

 

3.1  
Securities Laws. The Investor acknowledges that the New Securities and the Conversion Shares, have not been registered
under the Securities Act and may only be disposed of pursuant to an available exemption from or in a transaction not subject to
the registration requirements of the Securities Act.

 

3.2  
Restrictive Legend. The Investor agrees to the imprinting of a legend, substantially in the form below, on the New Securities
and Conversion Shares:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR
IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS.

 

    	 	-4-	 

     

    

 

ARTICLE
IV

MISCELLANEOUS

 

4.1  
Fees and Expenses. The Company has agreed to pay certain legal fees of Investor’s counsel in the aggregate principal
amount of $20,244.50. Except as set forth in the preceding sentence, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the New Securities.

 

4.2  
Entire Agreement; Amendments. This Agreement together with the exhibits and schedules hereto, dated as of the Execution
Date, contains the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.

 

4.3  
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email at the email address specified in this Section prior to 6:00 p.m.
(Eastern time) on a business day, against electronic confirmation thereof, (ii) the business day after the date of transmission,
if such notice or communication is delivered via facsimile at the facsimile number or email at the email address specified in
this Agreement later than 6:00 p.m. (Eastern time) on any date, against electronic confirmation thereof, (iii) the business day
following the date of mailing, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the
party to whom such notice is required to be given. The address for such notices and communications shall be as follows:

 

	 	If to the Company:	Avant Diagnostics, Inc.
	 	 	1050 30th Street NW Suite 107
	 	 	Washington, DC 20007
	 	 	Attention: Scott VanderMeer, Interim CFO
	 	 	Email: scott@avantdiagnostics.com 
	 	 	 
	 	With copies to (which shall	 
	 	not constitute notice):	Sheppard, Mullin, Richter & Hampton LLP
	 	 	30 Rockefeller Plaza, 39th Floor
	 	 	New York, NY 10112
	 	 	Facsimile No.: (917) 438-6137
	 	 	Email: scohen@sheppardmullin.com 
	 	 	Attn: Stephen A. Cohen

 

	 	If
    to the Investor: 	At
    the physical and electronic address of the Investor set forth on the signature page to this Agreement.

 

or
such other physical and electronic address as may be designated in writing hereafter, in the same manner, by such person or entity.

 

4.4  
Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in
the case of an amendment, by the Company and by the Investor. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the
exercise of any such right accruing to it thereafter.

 

    	 	-5-	 

     

    

  

4.5  
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.

 

4.6  
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Investor may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Company.

 

4.7  
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person or entity.

 

4.8    
Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the
State of New York, without regard to the principles of conflicts of law thereof. The Company and the Investor irrevocably consent
to the jurisdiction of the United States federal courts and state courts located in the State of New York in any suit or proceeding
based on or arising under this Agreement and irrevocably agree that all claims in respect of such suit or proceeding may be determined
in such courts.

 

4.9  
Survival. The representations and warranties contained herein shall survive the closing of the transactions contemplated
by this Agreement. The agreements and covenants contained herein shall survive the Closing and the delivery of the New Securities
until the expiration of the applicable statute of limitations (if any) therefor.

 

4.10   
Execution. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that all parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or a scanned copy via electronic mail, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile or
scanned signature page were an original thereof.

 

4.11    
Severability. In case any one or more of the provisions of this Agreement shall be invalid or unenforceable in any respect,
the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired
thereby and the parties will attempt to agree upon a valid and enforceable provision which shall be a reasonable substitute therefor,
and upon so agreeing, shall incorporate such substitute provision in this Agreement.

 

4.12   
Further Assurances. The parties hereto agree that each shall execute and deliver any and all further agreements, instruments,
certificates and other documents, and shall take any and all action, as any of the parties hereto may reasonably deem necessary
or desirable in order to carry out the intent of the parties to this Agreement.

 

4.13    
Attorneys’ Fees. If either party shall commence an action or proceeding to enforce any provisions relating to the
obligations to close the transactions contemplated by this Agreement prior to the Closing, then the prevailing party in such action
or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred with
the investigation, preparation and prosecution of such action or proceeding.

 

4.14  Construction.
The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to revise this Agreement
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of this Agreement or any amendments hereto.

 

[signature
page follows]

 

    	 	-6-	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Exchange Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	 	COMPANY:
	 	 
	 	AVANT DIAGNOSTICS, INC.
	 	 
	 	By: 	    
	 	Name: 	 
	 	Title: 	 

 

[additional
signature page follows]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Company Signature Page to Exchange Agreement]

 

    	 	-7-	 

     

    

  

INVESTOR:

 

___________________

 

	By: 	    	 
	Name: 	 	 
	Title: 	 	 

 

Email
Address of Authorized Signatory: ____________________________

 

Facsimile
Number of Authorized Signatory: ________________________

 

Address
for Notice to Investor:

 

[Investor
Signature Page to Exchange Agreement]

 

    	 	-8-	 

     

    

 

Exhibit
A

 

[Form
of Certificate of Designation of the Rights and Preferences of the Series A Preferred Stock]

 

    	 	-9-	 

     

    

 

Exhibit
B

 

[Form
of Certificate of Designation of the Rights and Preferences of the Series B Preferred Stock]

 

    	 	-10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]